Exoscrt Derma Signal Kit Srlv
NDC Package 72951-110-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Exoscrt Derma Signal Kit Srlv is ■ Mix Vial 1(Lyophilized Powder) and Vial 2(Diluent) thoroughly.Apply a proper amount of mixture around the facial area.* One time use ONLY. Marketed by Exocobio Inc., this product is identified by NDC 72951-110.

Identification & Billing

NDC Package Code
72951-110-01
Package Description
1 KIT in 1 CARTON * 20 mg in 1 VIAL * 5 mL in 1 VIAL
Product Code
72951-110
11-Digit Billing Format
72951011001

Clinical Specifications

Proprietary Name
Exoscrt Derma Signal Kit Srlv
Dosage Form
-
Usage Information
■ Mix Vial 1(Lyophilized Powder) and Vial 2(Diluent) thoroughly.Apply a proper amount of mixture around the facial area.* One time use ONLY.

Regulatory & Marketing

Labeler Name
Exocobio Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
10-01-2021
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72951-110-01 identifies a specific commercial package of 1 kit in 1 carton * 20 mg in 1 vial * 5 ml in 1 vial of Exoscrt Derma Signal Kit Srlv, labeled by Exocobio Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Exocobio Inc. on October 01, 2021. The current certification is valid through December 31, 2022.

How is this Exocobio Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72951011001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72951-110-01
11-Digit CMS (5-4-2)
72951-0110-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.